The Pharma Files

In 1951, one of the most respected scientists in America called a Chicago press conference to announce a cure for cancer. He was no quack. He had represented the United States at the Nuremberg medical trials, and when he spoke, people believed him. This episode follows Krebiozen — from a Yugoslav doctor who claimed he’d distilled it from the blood of horses, to a fraud trial that ran nine months, to a United States senator’s crusade to keep it alive. The drug never had much evidence behind it. What it had was credibility, and that carried it for more than a decade. Then the FDA finally analyzed a sample and found the miracle cure was a common substance already sitting in everyone’s muscles, creatine. For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com

A woman with multiple sclerosis appeared on national television and said that bee stings had let her get out of her wheelchair. The phones started ringing, and they didn't stop. This episode follows the century-old idea behind bee venom therapy — from an Austrian physician's 1888 rheumatism paper to a Hungarian immigrant practicing in Manhattan to Charles Mraz, a Vermont beekeeper who spent six decades stinging patients for free and died in 1999 still believing he was helping them. The science behind it was never entirely implausible: bee venom contains a potent anti-inflammatory compound, MS is an autoimmune disease, and the logic seemed to track. Then researchers ran a controlled trial. For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com

In 1891, a young surgeon named William Coley watched a teenage patient die of sarcoma and couldn't let it go. He went looking for a man who had supposedly beaten the same disease after contracting a severe bacterial infection — and found him, cancer-free, in a tenement on the Lower East Side of Manhattan. What followed was forty years of documented tumor regressions, fierce institutional resistance, and a treatment that was ultimately buried by the rise of radiation and chemotherapy. This episode traces how Coley stumbled onto the foundational principle of cancer immunotherapy a century before medicine had the language to understand it — and how his daughter, with no scientific training and a $2,000 loan, kept the idea alive long enough for the rest of medicine to catch up. For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com

In 1927, a wealthy Pittsburgh socialite injured his arm on a train and was handed a bottle of certified radioactive water as a remedy. He drank it daily for three years — eventually consuming somewhere between 1,000 and 1,500 bottles. By 1931, his bones were dissolving from the inside. This episode traces how radium went from Nobel Prize-winning discovery to prestige wellness product, how an unlicensed fraudster bottled it and sold it to the American elite, and why the people drinking it weren’t foolish — they were simply living in a moment when radiation seemed like the future, and nobody had yet learned what the future cost. For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com

In 1992, a businessman published a book called Sharks Don’t Get Cancer — and overnight, a legitimate line of Harvard and MIT cancer research became the justification for a multimillion-dollar supplement industry. This episode traces how real science, carefully caveated by the researchers who produced it, got stripped of its caveats, tested on desperate patients without controls, and sold in health stores across America before a single properly designed trial had been run. For the full written case file, visit thepharmafiles.substack.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thepharmafiles.substack.com